Parkinson disease in twins: An etiologic study

JAMA

Volumn 281, Issue 4, 1999, Pages 341-346

  Tanner, Caroline M ^a   Ottman, Ruth ^b   Goldman, Samuel M ^a   Ellenberg, Jonas ^c,d   Chan, Piu ^a   Mayeux, Richard ^b   Langston, J William ^a  

^a PARKINSON S INSTITUTE   (United States)

^b and Epidemiology   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; DIZYGOTIC TWINS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; TREMOR;

EID: 0033608187     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.4.341     Document Type: Article

References (44)

1. Langston JW, Ballard PA, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979-980.
2. Burns RS, Markey SP, Phillips JM, Chiueh CC. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Can J Neurol Sci. 1984;11(suppl 1):166-168.
3. Langston JW, Forno LS, Rebert CS, Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 1984;292.390-394.
4. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synudein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047.
5. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18:106-108.
6. Gasser T, Mueller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Cenet. 1998;18:262-265.
7. Marder K, Tang MX, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology. 1996;47:155-160.
8. 209A) in 100 patients with younger onset Parkinson's disease. Neurology. 1998;50:513-514.
9. Chan P, Jiang X, Fomo LS, Di Monte DA, Tanner CM, Langston JW. Absence of mutations in the coding region of the a-synuclein gene in pathologically proven Parkinson's disease. Neurology. 1998;50:1136-1137
10. Jablon S, Neel JV, Gershowitz H, Atkinson GF. The NAS-NRC twin panel. Am J Hum Genet. 1967;19: 133-161.
11. Breitner JC, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans, III: detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol. 1995; 52:763-771.
12. Tanner CM, Gilley DW, Goetz CG. Abrief screening questionnaire for parkinsonism. Ann Neurol. 1990; 28:267.
13. Gallo JJ, Breitner JC. Alzheimer's disease in the NAS-NRC Registry of Aging Twin Veterans, IV: performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med. 1995;25:1211-1219.
14. Brass LM, Carrano D, Hartigan PM, Concato J, Page WF. Genetic risk for stroke. Neurology. 1996; 46(suppl 2):A212.
15. Seddon JM, Samelson LJ, Page WF, Neale MC. Twin study of macular degeneration. Invest Ophthalmol Vis Sci. 1997;38(suppl):S676.
16. Page WF, Braun MM, Partin AW, Caporaso N, Walsh P. Heredity and prostate cancer a study of World War II veteran twins. Prostate. 1997;33:240-245.
17. Tanner CM, Ellenberg JH, Mayeux R, Ottman R, Langston JW. A sensitive and specific screening method for Parkinson's disease (PD). Neurology. 1994;44 (suppl 2):A136.
18. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992;7:2-13.
19. Hammond HA, Jin L, Zhong Y, Caskey CT, Chakraborty R. Evaluation of 13 short tandem repeat loci for use in personal identification applications. Am J Hum Genet. 1994;55:175-189.
20. Cederlof R, Friberg L, Jonsson E, Kaij L. Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genet Med Gemellol (Roma). 1961;11:338-342.
21. Torgersen S. The determination of twin zygosity by means of a mailed questionnaire. Acta Genet Med Gemellol (Roma). 1979;28:225-236.
22. Smith C. Concordance in twins: methods and interpretation. Am J Hum Genet. 1974;26:454-466.
23. Reich T, James JW, Morris CA. The use of multiple thresholds in determining the mode of transmission of semi-continuous traits. Ann Hum Genet 1972; 36:163-184.
24. Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. Neurol Clin. 1996;14:317-335.
25. Gudmundsson KR. A clinical survey of parkinsonism in Iceland. Acta Neurol Scand. 1967;43(suppl 33): 1-61.
26. Pembrey ME. Discordant identical twins, II: parkinsonism. Practitioner. 1972;209:240-243.
27. Kissel P, Andre JM. Parkinson's disease and anosmia in monozygotic twin sisters. J Hum Genet 1976; 24:113-117.
28. Jankovic J, Reches A. Parkinson's disease in monozygotic twins. Ann Neurol. 1986;19:405-408.
29. Koller W, O'Hara R, Nutt J, Young J, Rubino F. Monozygotic twins with Parkinson's disease. Ann Neurol. 1986;19:402-405.
30. Umehara F, Nomoto M, Usuki F, Matsumoto W, Osame M. Juvenile parkinsonism in monozygotic twins. Rinsho Shinkeigaku. 1991;31:306-309.
31. Duvoisin RC, Eldridge R, Williams A, Nutt J, Calne D. Twin study of Parkinson's disease. Neurology. 1981; 31:77-80.
32. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983; 33:815-824.
33. Zimmerman TR, Bhatt M, Calne DB, Duvoisin RC Parkinson's disease in monozygotic twins: a followup. Neurology. 1991;41(suppl 1):255.
34. Marsden CD. Twins and Parkinson's disease J Neurol Neurosurg Psychiatry. 1987;50:105-106.
35. Marttila RJ, Kaprio J, Koshewvuo M, Rinne UK Parkinson's disease in a nationwide twin cohort. Neurology. 1988;38:1217-1219.
36. Vieregge P, Schiffke KA, Friedrich HJ, Muller B, Ludin HP. Parkinson's disease in twins. Neurology. 1992;42:1453-1461.
37. Johnson WG, Hodge SE, Duvoisin R. Twin studies and the genetics of Parkinson's disease - a reappraisal. Mov Disord. 1990;5:187-194.
38. Mayeux R, Marder K, Cote LJ, et al The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995;142:820-827.
39. Melcon MO, Anderson DW, Vergara RH, Rocca WA. Prevalence of Parkinson's disease in Junin, Buenos Aires Province, Argentina. Mov Disord. 1997;12:197-205.
40. Morgante L, Rocca WA, Di Rosa AE, et al, for the Sicilian Neuro-Epidemiologic Study (SNES) Group. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology. 1992;42:1901-1907.
41. Wang SJ, Fuh JL, Teng EL, et al. A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen. Arch Neurol. 1996;53:66-71.
42. Duvoisin RC, Johnson WG. Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson's disease. Brain Pathol. 1992;2: 309-320.
43. Brooks DJ. Parkinson's disease: a single clinical entity? QJM. 1995;88:81-91.
44. Denson MA, Wszolek ZK. Familial parkinsonism: our experience and review. Parkinsonism Related Disord. 1995;1:35-46.